Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eyelid Diseases | 9 | 2024 | 156 | 3.970 |
Why?
|
Eyelid Neoplasms | 5 | 2024 | 88 | 2.520 |
Why?
|
Lacrimal Apparatus | 5 | 2022 | 224 | 2.170 |
Why?
|
Lacrimal Apparatus Diseases | 4 | 2022 | 72 | 2.060 |
Why?
|
Orbital Neoplasms | 4 | 2019 | 223 | 1.750 |
Why?
|
Eye Neoplasms | 3 | 2020 | 306 | 1.690 |
Why?
|
Dacryocystitis | 3 | 2022 | 68 | 1.660 |
Why?
|
Eyelids | 9 | 2024 | 279 | 1.620 |
Why?
|
Carcinoma, Adenoid Cystic | 3 | 2020 | 263 | 1.620 |
Why?
|
Retinal Pigment Epithelium | 11 | 2015 | 309 | 1.550 |
Why?
|
Conjunctival Neoplasms | 3 | 2024 | 78 | 1.270 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2022 | 180 | 1.250 |
Why?
|
Ciliary Body | 2 | 2020 | 168 | 1.200 |
Why?
|
Ophthalmologic Surgical Procedures | 4 | 2019 | 354 | 1.120 |
Why?
|
Eye Diseases | 4 | 2023 | 660 | 1.100 |
Why?
|
Edema | 2 | 2023 | 765 | 1.070 |
Why?
|
Cosmetic Techniques | 2 | 2018 | 150 | 1.050 |
Why?
|
Blepharoplasty | 2 | 2023 | 61 | 0.970 |
Why?
|
Conjunctival Diseases | 3 | 2020 | 109 | 0.950 |
Why?
|
Hyaluronic Acid | 2 | 2018 | 484 | 0.950 |
Why?
|
Macular Degeneration | 5 | 2023 | 1015 | 0.920 |
Why?
|
Melanosomes | 2 | 2014 | 34 | 0.870 |
Why?
|
Sweat Gland Neoplasms | 2 | 2021 | 111 | 0.800 |
Why?
|
Corneal Diseases | 2 | 2019 | 535 | 0.800 |
Why?
|
Blinking | 2 | 2020 | 135 | 0.790 |
Why?
|
Angioedema | 1 | 2023 | 184 | 0.770 |
Why?
|
Optic Nerve Diseases | 2 | 2022 | 342 | 0.760 |
Why?
|
Poroma | 1 | 2021 | 9 | 0.760 |
Why?
|
Ophthalmia, Sympathetic | 1 | 2021 | 18 | 0.760 |
Why?
|
Lacrimal Duct Obstruction | 1 | 2022 | 53 | 0.760 |
Why?
|
Neoplasms, Basal Cell | 1 | 2021 | 30 | 0.740 |
Why?
|
Wet Macular Degeneration | 1 | 2023 | 165 | 0.740 |
Why?
|
Keratosis, Seborrheic | 1 | 2021 | 29 | 0.730 |
Why?
|
Graves Ophthalmopathy | 4 | 2024 | 135 | 0.730 |
Why?
|
Dacryocystorhinostomy | 1 | 2022 | 78 | 0.730 |
Why?
|
Nasolacrimal Duct | 1 | 2022 | 79 | 0.730 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2022 | 87 | 0.730 |
Why?
|
Conjunctiva | 3 | 2022 | 477 | 0.720 |
Why?
|
Epidermal Cyst | 2 | 2018 | 63 | 0.710 |
Why?
|
Adenocarcinoma, Sebaceous | 1 | 2020 | 21 | 0.700 |
Why?
|
Sebaceous Gland Neoplasms | 1 | 2020 | 40 | 0.690 |
Why?
|
Iris Neoplasms | 1 | 2020 | 13 | 0.690 |
Why?
|
Choroidal Neovascularization | 1 | 2023 | 364 | 0.670 |
Why?
|
Iris Diseases | 1 | 2020 | 36 | 0.670 |
Why?
|
Ophthalmic Nerve | 1 | 2019 | 42 | 0.650 |
Why?
|
Orbit | 7 | 2022 | 459 | 0.650 |
Why?
|
Pigmentation Disorders | 1 | 2020 | 105 | 0.650 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2019 | 64 | 0.640 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2019 | 53 | 0.640 |
Why?
|
Ceruloplasmin | 4 | 2015 | 57 | 0.630 |
Why?
|
Blepharoptosis | 1 | 2020 | 145 | 0.630 |
Why?
|
Iris | 1 | 2020 | 232 | 0.620 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 219 | 0.620 |
Why?
|
Chalazion | 1 | 2018 | 10 | 0.610 |
Why?
|
Orbital Diseases | 2 | 2020 | 178 | 0.610 |
Why?
|
Acrylates | 1 | 2018 | 75 | 0.600 |
Why?
|
Carcinoid Tumor | 1 | 2020 | 225 | 0.600 |
Why?
|
Granuloma, Foreign-Body | 1 | 2018 | 41 | 0.600 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2017 | 38 | 0.580 |
Why?
|
RNA, Neoplasm | 1 | 2020 | 749 | 0.580 |
Why?
|
Nerve Transfer | 1 | 2019 | 132 | 0.580 |
Why?
|
Nevus | 1 | 2019 | 205 | 0.580 |
Why?
|
Eosinophilia | 1 | 2022 | 556 | 0.580 |
Why?
|
Facial Dermatoses | 1 | 2018 | 87 | 0.580 |
Why?
|
Triamcinolone Acetonide | 1 | 2018 | 105 | 0.570 |
Why?
|
Scleritis | 1 | 2018 | 96 | 0.570 |
Why?
|
Visual Acuity | 4 | 2020 | 2714 | 0.560 |
Why?
|
Cocaine | 1 | 2022 | 947 | 0.550 |
Why?
|
Gelatin | 1 | 2018 | 231 | 0.540 |
Why?
|
Fasciitis, Necrotizing | 1 | 2017 | 79 | 0.540 |
Why?
|
Cysts | 2 | 2019 | 685 | 0.540 |
Why?
|
Sclera | 1 | 2018 | 189 | 0.540 |
Why?
|
Keratins | 1 | 2017 | 499 | 0.530 |
Why?
|
Mucorales | 1 | 2016 | 35 | 0.530 |
Why?
|
Erythema | 1 | 2017 | 261 | 0.510 |
Why?
|
Hemostatics | 1 | 2018 | 246 | 0.510 |
Why?
|
Laser Coagulation | 1 | 2018 | 333 | 0.500 |
Why?
|
Amyloidosis | 2 | 2020 | 877 | 0.500 |
Why?
|
Carcinoma, Basal Cell | 1 | 2021 | 565 | 0.500 |
Why?
|
Eye Infections, Fungal | 1 | 2016 | 99 | 0.490 |
Why?
|
Mucormycosis | 1 | 2016 | 102 | 0.490 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2021 | 4058 | 0.470 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 542 | 0.460 |
Why?
|
Eye Infections, Bacterial | 1 | 2017 | 239 | 0.460 |
Why?
|
Foreign Bodies | 1 | 2018 | 403 | 0.450 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2014 | 204 | 0.450 |
Why?
|
Vision Disorders | 2 | 2019 | 1092 | 0.440 |
Why?
|
Nerve Regeneration | 1 | 2019 | 797 | 0.440 |
Why?
|
Macular Edema | 1 | 2017 | 387 | 0.430 |
Why?
|
Neurilemmoma | 1 | 2018 | 522 | 0.430 |
Why?
|
Cataract Extraction | 1 | 2017 | 464 | 0.430 |
Why?
|
Exophthalmos | 2 | 2024 | 100 | 0.420 |
Why?
|
Ferric Compounds | 1 | 2014 | 376 | 0.410 |
Why?
|
Streptococcal Infections | 1 | 2017 | 619 | 0.410 |
Why?
|
Glucocorticoids | 2 | 2021 | 2167 | 0.400 |
Why?
|
Melanins | 1 | 2014 | 292 | 0.400 |
Why?
|
Staphylococcal Infections | 1 | 2021 | 1398 | 0.400 |
Why?
|
Hydrogels | 1 | 2018 | 744 | 0.400 |
Why?
|
Skin Neoplasms | 3 | 2021 | 5863 | 0.400 |
Why?
|
Intraocular Pressure | 1 | 2018 | 1304 | 0.380 |
Why?
|
Iron Metabolism Disorders | 1 | 2011 | 24 | 0.380 |
Why?
|
Cornea | 1 | 2019 | 1316 | 0.380 |
Why?
|
Retinal Vessels | 1 | 2017 | 864 | 0.380 |
Why?
|
Anti-Inflammatory Agents | 2 | 2018 | 1810 | 0.380 |
Why?
|
Immunocompromised Host | 1 | 2016 | 863 | 0.360 |
Why?
|
Transferrin | 1 | 2011 | 283 | 0.350 |
Why?
|
Humans | 68 | 2024 | 768171 | 0.350 |
Why?
|
Collagen | 1 | 2018 | 2645 | 0.340 |
Why?
|
Cellulitis | 2 | 2022 | 206 | 0.340 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1640 | 0.330 |
Why?
|
Iron | 8 | 2015 | 1813 | 0.320 |
Why?
|
Middle Aged | 30 | 2024 | 223487 | 0.320 |
Why?
|
Orbital Fractures | 2 | 2020 | 109 | 0.310 |
Why?
|
Ferritins | 1 | 2011 | 601 | 0.310 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 1642 | 0.300 |
Why?
|
Eye Injuries, Penetrating | 2 | 2020 | 121 | 0.300 |
Why?
|
Glaucoma | 1 | 2018 | 1194 | 0.300 |
Why?
|
Optic Nerve | 2 | 2022 | 571 | 0.290 |
Why?
|
Pain, Postoperative | 1 | 2018 | 1765 | 0.280 |
Why?
|
Iron Chelating Agents | 3 | 2015 | 141 | 0.270 |
Why?
|
Retrospective Studies | 16 | 2024 | 81760 | 0.270 |
Why?
|
Neurodegenerative Diseases | 2 | 2015 | 1094 | 0.270 |
Why?
|
Up-Regulation | 2 | 2015 | 4149 | 0.260 |
Why?
|
Retinal Diseases | 1 | 2011 | 710 | 0.250 |
Why?
|
Disease Management | 1 | 2016 | 2535 | 0.250 |
Why?
|
Female | 31 | 2024 | 397187 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8648 | 0.230 |
Why?
|
Debridement | 2 | 2017 | 494 | 0.220 |
Why?
|
Quality Improvement | 1 | 2019 | 3857 | 0.220 |
Why?
|
Conjunctivitis | 1 | 2024 | 153 | 0.220 |
Why?
|
Anti-Bacterial Agents | 5 | 2022 | 7477 | 0.200 |
Why?
|
Meibomian Glands | 1 | 2022 | 74 | 0.200 |
Why?
|
Male | 28 | 2024 | 364731 | 0.200 |
Why?
|
Immunohistochemistry | 4 | 2019 | 11095 | 0.190 |
Why?
|
Membrane Proteins | 3 | 2015 | 7876 | 0.190 |
Why?
|
Intravitreal Injections | 1 | 2023 | 401 | 0.190 |
Why?
|
Frontal Bone | 2 | 2018 | 106 | 0.190 |
Why?
|
Keratoacanthoma | 1 | 2021 | 33 | 0.190 |
Why?
|
Staining and Labeling | 2 | 2018 | 1080 | 0.180 |
Why?
|
Endothelial Growth Factors | 1 | 2023 | 672 | 0.180 |
Why?
|
Biopsy | 4 | 2020 | 6792 | 0.180 |
Why?
|
Ophthalmic Artery | 1 | 2020 | 57 | 0.180 |
Why?
|
Eye Burns | 1 | 2020 | 64 | 0.170 |
Why?
|
Aged, 80 and over | 10 | 2024 | 59626 | 0.170 |
Why?
|
Microscopy, Acoustic | 1 | 2020 | 47 | 0.170 |
Why?
|
Eye Foreign Bodies | 1 | 2020 | 51 | 0.170 |
Why?
|
Rheumatoid Nodule | 1 | 2019 | 15 | 0.160 |
Why?
|
Oculomotor Muscles | 2 | 2022 | 405 | 0.160 |
Why?
|
Trichiasis | 1 | 2018 | 5 | 0.160 |
Why?
|
Injections, Intraocular | 1 | 2018 | 36 | 0.160 |
Why?
|
Hidrocystoma | 1 | 2018 | 10 | 0.150 |
Why?
|
Corneal Neovascularization | 1 | 2020 | 184 | 0.150 |
Why?
|
Ophthalmoplegia | 1 | 2019 | 168 | 0.150 |
Why?
|
Facial Neoplasms | 1 | 2019 | 126 | 0.150 |
Why?
|
Persistent Hyperplastic Primary Vitreous | 1 | 2017 | 7 | 0.150 |
Why?
|
S100 Proteins | 1 | 2018 | 216 | 0.150 |
Why?
|
Lens Capsule, Crystalline | 1 | 2017 | 38 | 0.150 |
Why?
|
Pyridones | 2 | 2015 | 819 | 0.150 |
Why?
|
Hemangioma, Cavernous | 1 | 2018 | 107 | 0.150 |
Why?
|
Abscess | 1 | 2021 | 606 | 0.150 |
Why?
|
Vimentin | 1 | 2018 | 257 | 0.150 |
Why?
|
Neurofibroma | 1 | 2018 | 95 | 0.150 |
Why?
|
Penicillin G | 1 | 2017 | 40 | 0.140 |
Why?
|
Scleroderma, Localized | 1 | 2018 | 85 | 0.140 |
Why?
|
Doxycycline | 1 | 2019 | 349 | 0.140 |
Why?
|
Prolactinoma | 1 | 2018 | 114 | 0.140 |
Why?
|
Submandibular Gland | 1 | 2017 | 85 | 0.140 |
Why?
|
Streptococcus | 1 | 2017 | 198 | 0.140 |
Why?
|
Whipple Disease | 1 | 2016 | 20 | 0.140 |
Why?
|
Granuloma | 1 | 2019 | 329 | 0.140 |
Why?
|
Cautery | 1 | 2017 | 73 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 8 | 2020 | 20762 | 0.130 |
Why?
|
Aged | 11 | 2024 | 171502 | 0.130 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4648 | 0.130 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8542 | 0.130 |
Why?
|
Hematoma | 1 | 2020 | 766 | 0.130 |
Why?
|
Gels | 1 | 2017 | 423 | 0.130 |
Why?
|
Vitreous Body | 1 | 2017 | 401 | 0.120 |
Why?
|
Lens, Crystalline | 1 | 2017 | 387 | 0.120 |
Why?
|
Iron Overload | 3 | 2015 | 245 | 0.120 |
Why?
|
Papillomaviridae | 1 | 2021 | 1140 | 0.120 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13586 | 0.120 |
Why?
|
Tears | 1 | 2017 | 254 | 0.120 |
Why?
|
Postoperative Complications | 1 | 2017 | 15833 | 0.120 |
Why?
|
gp100 Melanoma Antigen | 1 | 2014 | 37 | 0.120 |
Why?
|
Monophenol Monooxygenase | 1 | 2014 | 72 | 0.120 |
Why?
|
Vitrectomy | 1 | 2017 | 392 | 0.120 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1105 | 0.120 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2014 | 105 | 0.120 |
Why?
|
Vancomycin | 1 | 2017 | 506 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 13013 | 0.110 |
Why?
|
Hydrogen Peroxide | 4 | 2011 | 741 | 0.110 |
Why?
|
Endophthalmitis | 1 | 2016 | 263 | 0.110 |
Why?
|
Protons | 1 | 2019 | 1113 | 0.110 |
Why?
|
Surgical Flaps | 1 | 2022 | 1682 | 0.110 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1972 | 0.110 |
Why?
|
SOX9 Transcription Factor | 1 | 2014 | 145 | 0.110 |
Why?
|
Angiogenesis Inhibitors | 1 | 2023 | 2057 | 0.110 |
Why?
|
Stromal Cells | 1 | 2019 | 1337 | 0.110 |
Why?
|
Complement C3 | 1 | 2015 | 434 | 0.110 |
Why?
|
Eye Proteins | 2 | 2014 | 628 | 0.110 |
Why?
|
Intestinal Absorption | 1 | 2014 | 401 | 0.110 |
Why?
|
Adult | 10 | 2024 | 223646 | 0.100 |
Why?
|
Oxidoreductases | 1 | 2014 | 410 | 0.100 |
Why?
|
Spectrometry, Mass, Secondary Ion | 1 | 2011 | 15 | 0.100 |
Why?
|
Endocarditis | 1 | 2016 | 352 | 0.100 |
Why?
|
Vitronectin | 1 | 2011 | 40 | 0.100 |
Why?
|
Lipofuscin | 1 | 2011 | 40 | 0.100 |
Why?
|
Blotting, Western | 3 | 2014 | 5028 | 0.100 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2012 | 147 | 0.100 |
Why?
|
Complement Membrane Attack Complex | 1 | 2011 | 105 | 0.100 |
Why?
|
Hydrazones | 2 | 2009 | 105 | 0.100 |
Why?
|
Retinal Neurons | 1 | 2012 | 67 | 0.100 |
Why?
|
Cytoprotection | 2 | 2009 | 200 | 0.090 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2015 | 642 | 0.090 |
Why?
|
Antifungal Agents | 1 | 2016 | 761 | 0.090 |
Why?
|
Aldehydes | 2 | 2009 | 170 | 0.090 |
Why?
|
Bone Morphogenetic Protein 6 | 1 | 2011 | 58 | 0.090 |
Why?
|
Morbidity | 1 | 2016 | 1755 | 0.090 |
Why?
|
Cells, Cultured | 4 | 2014 | 19025 | 0.090 |
Why?
|
Bacteria | 1 | 2021 | 2216 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1907 | 0.090 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2012 | 203 | 0.090 |
Why?
|
Retinal Degeneration | 2 | 2011 | 414 | 0.080 |
Why?
|
Chelating Agents | 1 | 2011 | 385 | 0.080 |
Why?
|
Boron Compounds | 1 | 2011 | 196 | 0.080 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1322 | 0.080 |
Why?
|
Prodrugs | 1 | 2011 | 274 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4913 | 0.080 |
Why?
|
Isonicotinic Acids | 1 | 2008 | 7 | 0.080 |
Why?
|
Oxidative Stress | 4 | 2015 | 3140 | 0.080 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1703 | 0.080 |
Why?
|
Integrases | 1 | 2011 | 520 | 0.080 |
Why?
|
Microscopy, Electron | 1 | 2011 | 2560 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6847 | 0.070 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39354 | 0.070 |
Why?
|
Tomography, Optical Coherence | 2 | 2017 | 2957 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6316 | 0.070 |
Why?
|
Child | 3 | 2020 | 80917 | 0.070 |
Why?
|
Mice, Knockout | 5 | 2014 | 14488 | 0.070 |
Why?
|
Adolescent | 3 | 2020 | 89169 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1169 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2019 | 3589 | 0.060 |
Why?
|
Melanoma | 1 | 2024 | 5706 | 0.060 |
Why?
|
Young Adult | 4 | 2020 | 60066 | 0.060 |
Why?
|
Fluorescent Antibody Technique, Indirect | 3 | 2011 | 424 | 0.060 |
Why?
|
Gestational Age | 1 | 2014 | 3621 | 0.060 |
Why?
|
Tissue Donors | 1 | 2014 | 2381 | 0.060 |
Why?
|
Radiodermatitis | 1 | 2024 | 61 | 0.060 |
Why?
|
Carrier Proteins | 2 | 2014 | 4939 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2892 | 0.060 |
Why?
|
Boronic Acids | 1 | 2008 | 915 | 0.060 |
Why?
|
RNA, Messenger | 3 | 2014 | 12801 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 4585 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3713 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2019 | 65379 | 0.050 |
Why?
|
Immunotherapy | 1 | 2019 | 4754 | 0.050 |
Why?
|
Antioxidants | 1 | 2011 | 1676 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3044 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 21538 | 0.050 |
Why?
|
Apoptosis | 2 | 2009 | 9527 | 0.050 |
Why?
|
Inflammation | 1 | 2022 | 10873 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18415 | 0.050 |
Why?
|
Mice, Transgenic | 4 | 2015 | 9561 | 0.050 |
Why?
|
Uveal Neoplasms | 1 | 2024 | 344 | 0.050 |
Why?
|
Cell Line | 5 | 2015 | 15602 | 0.050 |
Why?
|
Mice | 8 | 2015 | 82049 | 0.040 |
Why?
|
Sphenoid Bone | 1 | 2021 | 176 | 0.040 |
Why?
|
Child, Preschool | 2 | 2020 | 42669 | 0.040 |
Why?
|
Eye Evisceration | 1 | 2019 | 22 | 0.040 |
Why?
|
Folliculitis | 1 | 2019 | 25 | 0.040 |
Why?
|
Eye Enucleation | 1 | 2019 | 128 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2015 | 11930 | 0.040 |
Why?
|
Neuroendoscopy | 1 | 2020 | 100 | 0.040 |
Why?
|
Mutation | 2 | 2015 | 30237 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2011 | 3703 | 0.040 |
Why?
|
Electroretinography | 2 | 2011 | 524 | 0.040 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2020 | 749 | 0.040 |
Why?
|
Apocrine Glands | 1 | 2018 | 31 | 0.040 |
Why?
|
Eye | 1 | 2022 | 712 | 0.040 |
Why?
|
Eccrine Glands | 1 | 2018 | 52 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 40220 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 36741 | 0.040 |
Why?
|
Animals | 9 | 2020 | 169285 | 0.040 |
Why?
|
Radiation Injuries | 1 | 2024 | 1198 | 0.030 |
Why?
|
Face | 1 | 2023 | 1031 | 0.030 |
Why?
|
Epididymitis | 1 | 2016 | 37 | 0.030 |
Why?
|
Orchitis | 1 | 2016 | 36 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18349 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13677 | 0.030 |
Why?
|
Ligands | 2 | 2015 | 3284 | 0.030 |
Why?
|
Cadaver | 1 | 2020 | 1364 | 0.030 |
Why?
|
Cell Death | 2 | 2011 | 1680 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2015 | 26 | 0.030 |
Why?
|
Ceftriaxone | 1 | 2016 | 175 | 0.030 |
Why?
|
Lymphoma | 1 | 2024 | 1898 | 0.030 |
Why?
|
Smad3 Protein | 1 | 2015 | 166 | 0.030 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2015 | 367 | 0.030 |
Why?
|
cis-trans-Isomerases | 1 | 2014 | 45 | 0.030 |
Why?
|
Otx Transcription Factors | 1 | 2014 | 42 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 54924 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4178 | 0.030 |
Why?
|
Rabbits | 1 | 2020 | 4773 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2015 | 22380 | 0.030 |
Why?
|
Documentation | 1 | 2020 | 917 | 0.030 |
Why?
|
Myositis | 1 | 2016 | 269 | 0.030 |
Why?
|
Hydroxyl Radical | 1 | 2011 | 82 | 0.020 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2011 | 199 | 0.020 |
Why?
|
Muscle Strength | 1 | 2015 | 640 | 0.020 |
Why?
|
Arthritis | 1 | 2016 | 684 | 0.020 |
Why?
|
United States | 1 | 2019 | 73039 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1606 | 0.020 |
Why?
|
Cell Survival | 2 | 2011 | 5789 | 0.020 |
Why?
|
Amines | 1 | 2011 | 280 | 0.020 |
Why?
|
Neuroglia | 1 | 2015 | 960 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9384 | 0.020 |
Why?
|
Receptors, Transferrin | 1 | 2011 | 300 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3517 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3334 | 0.020 |
Why?
|
Pyridinium Compounds | 1 | 2009 | 81 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2237 | 0.020 |
Why?
|
Copper | 1 | 2011 | 368 | 0.020 |
Why?
|
Retinoids | 1 | 2009 | 99 | 0.020 |
Why?
|
Staurosporine | 1 | 2009 | 241 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2009 | 412 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2011 | 1951 | 0.020 |
Why?
|
Ultrasonography | 1 | 2019 | 6004 | 0.020 |
Why?
|
Ion Channels | 1 | 2011 | 1043 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 696 | 0.020 |
Why?
|
Motor Activity | 1 | 2015 | 2711 | 0.020 |
Why?
|
Binding Sites | 1 | 2014 | 6019 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 1752 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2227 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20225 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2014 | 4280 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2019 | 3781 | 0.010 |
Why?
|
Models, Genetic | 1 | 2014 | 3447 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3814 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2634 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2011 | 2202 | 0.010 |
Why?
|
Kinetics | 1 | 2011 | 6330 | 0.010 |
Why?
|
Body Weight | 1 | 2014 | 4627 | 0.010 |
Why?
|
Administration, Oral | 1 | 2011 | 4034 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2015 | 4413 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 6231 | 0.010 |
Why?
|
Chromatin | 1 | 2014 | 2981 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6082 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 3782 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36535 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 2152 | 0.010 |
Why?
|
Antigens, CD | 1 | 2011 | 4035 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5797 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 13045 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 30009 | 0.010 |
Why?
|
MicroRNAs | 1 | 2014 | 3803 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16726 | 0.010 |
Why?
|
Neurons | 1 | 2015 | 9514 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12171 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9262 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23648 | 0.010 |
Why?
|
Brain | 1 | 2015 | 27362 | 0.000 |
Why?
|